Clinical Trials for Prinicipal Investigator: Angela G Fleischman

5 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-03 Role of Inflammation in the Pathogenesis of Myeloproliferative Neoplasm Open
UCI-14-89 [BIOREPOSITORY] Hematologic Malignancies Biorepository for human research Open
UCI-17-31 An Open-Label Phase II Study of Itacitinib (INCB039110) in Combination with Low Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects with Myelofibrosis Open
UCI-17-72 Evaluating the Microbiome in Myeloproliferative Neoplasm Open
UCI-18-17 Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) Open